
Sign up to save your podcasts
Or


A company called Ambrosia Health signed up about 150 patients for a novel anti-aging procedure: young blood plasma transfusions. The only problem was the FDA. This week on Decrypted, the story of a startup that claimed it could restore lost youth with young people's blood. We’ll hear from a patient who got the treatment, the researchers who say it endangered patients, and the scientists who believe the idea isn’t as crazy as it seems.
See omnystudio.com/listener for privacy information.
By Bloomberg4.5
968968 ratings
A company called Ambrosia Health signed up about 150 patients for a novel anti-aging procedure: young blood plasma transfusions. The only problem was the FDA. This week on Decrypted, the story of a startup that claimed it could restore lost youth with young people's blood. We’ll hear from a patient who got the treatment, the researchers who say it endangered patients, and the scientists who believe the idea isn’t as crazy as it seems.
See omnystudio.com/listener for privacy information.

404 Listeners

1,173 Listeners

2,177 Listeners

1,955 Listeners

418 Listeners

354 Listeners

1,651 Listeners

1,095 Listeners

3,993 Listeners

1,448 Listeners

194 Listeners

6,069 Listeners

30 Listeners

525 Listeners

5,528 Listeners

4 Listeners

155 Listeners

58 Listeners

233 Listeners

228 Listeners

63 Listeners

75 Listeners

84 Listeners

397 Listeners

18 Listeners

12 Listeners

7 Listeners

2 Listeners

72 Listeners